Delivery of VEGF siRNA via NPs downregulated VEGF expression in HCC in vivo and in vitro and generated strong anti-angiogenic effects in the TME of a mouse model of orthotopic HCC, leading to significant tumor regression [160]. This evidence concerns the gene VEGFA and hepatocellular carcinoma.